You turn to us for voices you won't hear anywhere else.

Sign up for Democracy Now!'s Daily Digest to get our latest headlines and stories delivered to your inbox every day.

European Union Officials Consider Use of Russian COVID-19 Vaccine

HeadlineApr 13, 2021

In Brussels, European Union officials are deciding whether to allow emergency use of Russia’s Sputnik V vaccine, after many European nations suspended use of AstraZeneca’s vaccine for younger people amid reports of rare incidents of blood clots. In clinical trials, the two-dose Sputnik V outperformed AstraZeneca with over 90% efficacy at preventing COVID-19.

Regeneron Pharmaceuticals has asked the U.S. Food and Drug Administration to expand emergency use of its monoclonal antibody cocktail. Regeneron says a clinical trial showed its drug reduced the risk of symptomatic infection by over 80% among people who lived in the same household as someone who tested positive for coronavirus.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top